Skip to main content
. 2013 Sep 17;57(11):1542–1549. doi: 10.1093/cid/cit593

Table 3.

Selected Risk Factors for Severe Disease

Risk Factor Mild-Moderatea Severe Univariate OR (95% CI) P Value Multivariate OR (95% CI) P Value
Transplant typeb
 Heart 11/105; 10% 3/43; 7% 0.71 (.18–2.72) .76
 Liver 15/105; 14% 9/43; 21% 1.59 (.63–3.90) .32
 Renal 56/105; 53% 21/43; 49% 0.84 (.41–1.70) .62
 Pancreas 1/105; 1% 2/43; 5% 5.07 (.56–45.9) .20
 Renal/pancreas 17/105; 16% 5/43; 12% 0.68 (.23–1.98) .48
 Lung 5/105; 5% 3/43; 7% 1.50 (.34–6.55) .59
Immunosuppression
 Calcineurin inhibitor 99/108; 92% 40/43; 93% 1.21 (.28–7.30) .99
 Mycophenolate 83/108; 76% 39/43; 92% 2.94 (1.00–8.71) .05 9.41 (1.27–66.1) .028
 Corticosteroid 86/108; 80% 28/43; 65% 0.48 (.22–1.04) .06
Organ involvement
 Pulmonary 85/108; 79% 37/43; 86% 2.94 (.99–8.71) .07
 Disseminated 83/108; 77% 39/43; 91% 0.37 (.13–1.05) .06
 Bone marrow 23/108; 21% 16/43; 37% 2.20 (1.02–4.70) .04 2.62 (.81–12.2) .098
 Liver 19/108; 18% 8/43; 19% 1.07 (.43–2.68) .89
 Spleen 10/108; 9% 9/43; 21% 2.50 (.99–6.78) .06
 Skin 4/108; 4% 1/43; 2% 0.62 (.07–5.63) .56
 Gastrointestinal 13/108; 12% 3/43; 7% 0.50 (.15–2.00) .56
 Central nervous system 6/108; 6% 4/43; 9% 1.74 (.47–6.45) .76
Fungemia 28/57; 49% 27/30; 90% 9.32 (2.72–32.1) .001 5.40 (1.24–23.4) .024
Median urine antigen, ng/mL (No. sent, range) 10.8 (101c; 0 to >19) 19 (40c; 0 to >19) 1.11 (1.05–1.18) .001 1.029 (.87–1.22) .73
Urine antigen >19 ng/mL 31% 56% 2.9 (1.30–6.20) .01 5.86 (.62–55.7) .124
Median serum antigen, ng/mL (No. sent, range) 11.6 (37c; 3.5 to >19) 10.2 (13c; 0 to >19) 1.016 (.97–1.07) .40

Abbreviations: CI, confidence interval; ng, nanograms; OR, odds ratio.

a Severity of 1 case could not be classified.

b One small bowel and 2 multiorgan nonrenal/pancreas transplants not included.

c No. of patients in whom results of the respective test were available.